[BRIEFING.COM] The S&P 500 (-0.1%) continues to hover at the 6,600 mark, while the Nasdaq Composite (-0.5%) faces a wider loss and the DJIA (+0.7%) broadens its gain for the day.
Eli Lilly (LLY 771.40, +6.69, +0.87%) trades higher today following the release of positive Phase 3 trial results for the company's experimental diabetes and weight-loss pill, orforglipron, which outperformed a competing drug from Novo Nordisk A/S (NVO 58.88, +1.68, +2.94%) in blood sugar control and weight loss metrics.
The health care sector is up a healthy 0.6% today, with AbbVie (ABBV 220.65, +4.39, +2.03%) leading the way after receiving an upgrade to Buy from Hold at Berenberg.
In other corporate news, StubHub (STUB) is indicated to open for trading at $25-$26 after its 34 million share IPO priced at $23.50.